Business Description
Daan Gene Co Ltd
NAICS : 325199
ISIN : CNE000001KP1
Share Class Description:
SZSE:002030: Class ACompare
Compare
Traded in other countries / regions
002030.China IPO Date
2004-08-09Description
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.31 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -1 | |||||
| Interest Coverage | 3.52 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 4.71 | |||||
| Beneish M-Score | -0.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39.5 | |||||
| 3-Year EBITDA Growth Rate | -45.6 | |||||
| 3-Year FCF Growth Rate | -54.1 | |||||
| 3-Year Book Growth Rate | 27.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.2 | |||||
| 9-Day RSI | 24.08 | |||||
| 14-Day RSI | 28.98 | |||||
| 6-1 Month Momentum % | -27.62 | |||||
| 12-1 Month Momentum % | -40.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.74 | |||||
| Quick Ratio | 3.57 | |||||
| Cash Ratio | 0.56 | |||||
| Days Inventory | 240.49 | |||||
| Days Sales Outstanding | 902.99 | |||||
| Days Payable | 333.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 26.68 | |||||
| Dividend Payout Ratio | 36.46 | |||||
| 3-Year Dividend Growth Rate | 378.2 | |||||
| Forward Dividend Yield % | 26.68 | |||||
| 5-Year Yield-on-Cost % | 7228.47 | |||||
| Shareholder Yield % | 24.83 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.76 | |||||
| Operating Margin % | 3.73 | |||||
| Net Margin % | -28.43 | |||||
| FCF Margin % | 56.58 | |||||
| ROE % | -3.14 | |||||
| ROA % | -2.53 | |||||
| ROIC % | 0.38 | |||||
| ROC (Joel Greenblatt) % | -7.6 | |||||
| ROCE % | -3.65 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 136.67 | |||||
| Shiller PE Ratio | 7.63 | |||||
| PEG Ratio | 2.45 | |||||
| PS Ratio | 8.9 | |||||
| PB Ratio | 1.08 | |||||
| Price-to-Tangible-Book | 1.21 | |||||
| Price-to-Free-Cash-Flow | 15.71 | |||||
| Price-to-Operating-Cash-Flow | 8.78 | |||||
| EV-to-EBIT | -24.74 | |||||
| EV-to-EBITDA | -24.74 | |||||
| EV-to-Revenue | 8.57 | |||||
| EV-to-FCF | 15.14 | |||||
| Price-to-Projected-FCF | 0.42 | |||||
| Price-to-Median-PS-Value | 1.03 | |||||
| Price-to-Graham-Number | 2.71 | |||||
| Price-to-Net-Current-Asset-Value | 2.53 | |||||
| Earnings Yield (Greenblatt) % | -4.04 | |||||
| FCF Yield % | 6.38 | |||||
| Forward Rate of Return (Yacktman) % | 35.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daan Gene Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,038.167 | ||
| EPS (TTM) (Â¥) | -0.211 | ||
| Beta | 0.77 | ||
| Volatility % | 41.26 | ||
| 14-Day RSI | 28.98 | ||
| 14-Day ATR (Â¥) | 0.20358 | ||
| 20-Day SMA (Â¥) | 7.087 | ||
| 12-1 Month Momentum % | -40.62 | ||
| 52-Week Range (Â¥) | 6.45 - 12.73 | ||
| Shares Outstanding (Mil) | 1,403.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Daan Gene Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Daan Gene Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Daan Gene Co Ltd Frequently Asked Questions
What is Daan Gene Co Ltd(SZSE:002030)'s stock price today?
The current price of SZSE:002030 is ¥6.56. The 52 week high of SZSE:002030 is ¥12.73 and 52 week low is ¥6.45.
When is next earnings date of Daan Gene Co Ltd(SZSE:002030)?
The next earnings date of Daan Gene Co Ltd(SZSE:002030) is .
Does Daan Gene Co Ltd(SZSE:002030) pay dividends? If so, how much?
The Dividend Yield %  of Daan Gene Co Ltd(SZSE:002030) is 26.68% (As of Today), Highest Dividend Payout Ratio of Daan Gene Co Ltd(SZSE:002030) was 36.46. The lowest was 0.01. And the median was 0.34. The  Forward Dividend Yield % of Daan Gene Co Ltd(SZSE:002030) is 26.68%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers